Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.54 USD | -7.09% | -9.69% | -32.31% |
May. 15 | Eagle Pharmaceuticals, Inc. Enters into a Third Amendment to Third Amended and Restated Credit Agreement | CI |
May. 06 | North American Morning Briefing : Stock Futures -2- | DJ |
Financials (USD)
Sales 2021 | 172M | Sales 2022 | 317M | Capitalization | 380M |
---|---|---|---|---|---|
Net income 2021 | -8M | Net income 2022 | 35M | EV / Sales 2021 | 3.44 x |
Net cash position 2021 | 67.84M | Net Debt 2022 | 10.19M | EV / Sales 2022 | 1.23 x |
P/E ratio 2021 |
-77
x | P/E ratio 2022 |
10.7
x | Employees | 134 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 65.14% |
Latest transcript on Eagle Pharmaceuticals, Inc.
1 day | +9.80% | ||
1 week | +1.87% | ||
Current month | +9.80% | ||
1 month | -13.61% | ||
3 months | -41.20% | ||
6 months | -35.97% | ||
Current year | -27.15% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Graves
CEO | Chief Executive Officer | 61 | 13-10-31 |
Steven B. Ratoff
DFI | Director of Finance/CFO | 81 | 07-02-28 |
Ryan Debski
CMP | Compliance Officer | - | 21-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven B. Ratoff
DFI | Director of Finance/CFO | 81 | 07-02-28 |
Jennifer Simpson
BRD | Director/Board Member | 55 | 19-08-27 |
Richard Edlin
BRD | Director/Board Member | 63 | 17-03-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.54% | 28 M€ | -1.28% | ||
0.25% | 25 M€ | -2.76% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 3.54 | -7.09% | 82 496 |
24-06-03 | 3.81 | +9.80% | 129,307 |
24-05-31 | 3.47 | +1.31% | 114,246 |
24-05-30 | 3.425 | +2.54% | 80,945 |
24-05-29 | 3.34 | -14.80% | 426,702 |
Delayed Quote Nasdaq, June 03, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-27.15% | 49.48M | |
+15.89% | 79.25B | |
+14.26% | 9.15B | |
+42.06% | 4.46B | |
-14.54% | 4.9B | |
+9.01% | 4.09B | |
+20.99% | 2.49B | |
-27.22% | 2.17B | |
+15.83% | 2.1B | |
-39.50% | 1.89B |
- Stock Market
- Equities
- EGRX Stock